Compare ARAY & OXSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARAY | OXSQ |
|---|---|---|
| Founded | 1990 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.1M | 144.4M |
| IPO Year | 2007 | N/A |
| Metric | ARAY | OXSQ |
|---|---|---|
| Price | $0.99 | $1.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 732.6K |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 22.95% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $450,902,000.00 | $40,142,565.00 |
| Revenue This Year | $3.82 | N/A |
| Revenue Next Year | $4.08 | $2.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1.51 | N/A |
| 52 Week Low | $0.91 | $1.56 |
| 52 Week High | $2.95 | $2.87 |
| Indicator | ARAY | OXSQ |
|---|---|---|
| Relative Strength Index (RSI) | 32.66 | 50.27 |
| Support Level | $1.00 | $1.83 |
| Resistance Level | $1.06 | $1.87 |
| Average True Range (ATR) | 0.06 | 0.04 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 34.85 | 56.95 |
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing and Diversified Insurance.